OLD National Bancorp IN Invests $235,000 in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

OLD National Bancorp IN purchased a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the fourth quarter, HoldingsChannel reports. The firm purchased 6,608 shares of the medical instruments supplier’s stock, valued at approximately $235,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. CWM LLC boosted its stake in shares of DENTSPLY SIRONA by 18.2% in the 4th quarter. CWM LLC now owns 5,175 shares of the medical instruments supplier’s stock worth $184,000 after buying an additional 796 shares during the last quarter. abrdn plc boosted its stake in shares of DENTSPLY SIRONA by 40.0% in the 4th quarter. abrdn plc now owns 111,494 shares of the medical instruments supplier’s stock worth $3,968,000 after buying an additional 31,852 shares during the last quarter. Cooke & Bieler LP boosted its stake in shares of DENTSPLY SIRONA by 18.3% in the 4th quarter. Cooke & Bieler LP now owns 7,061,910 shares of the medical instruments supplier’s stock worth $251,333,000 after buying an additional 1,092,922 shares during the last quarter. John G Ullman & Associates Inc. boosted its stake in shares of DENTSPLY SIRONA by 8.7% in the 4th quarter. John G Ullman & Associates Inc. now owns 129,730 shares of the medical instruments supplier’s stock worth $4,617,000 after buying an additional 10,400 shares during the last quarter. Finally, Ninety One UK Ltd boosted its stake in shares of DENTSPLY SIRONA by 16.1% in the 4th quarter. Ninety One UK Ltd now owns 1,201,198 shares of the medical instruments supplier’s stock worth $42,751,000 after buying an additional 166,963 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Up 0.7 %

NASDAQ:XRAY opened at $30.57 on Friday. DENTSPLY SIRONA Inc. has a 52 week low of $26.27 and a 52 week high of $43.24. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The business’s 50-day simple moving average is $32.59 and its two-hundred day simple moving average is $32.78.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $972.61 million. During the same period in the previous year, the firm posted $0.46 earnings per share. The business’s revenue was up 3.0% compared to the same quarter last year. On average, equities research analysts predict that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current year.

DENTSPLY SIRONA Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 2.09%. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA’s payout ratio is -103.22%.

Wall Street Analyst Weigh In

XRAY has been the topic of a number of research reports. Piper Sandler raised their price target on DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a “neutral” rating in a research note on Friday, January 12th. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, January 19th. Barrington Research reaffirmed an “outperform” rating and issued a $41.00 target price on shares of DENTSPLY SIRONA in a report on Thursday, April 18th. Needham & Company LLC reaffirmed a “buy” rating and issued a $42.00 target price on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. Finally, SVB Leerink began coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They issued an “outperform” rating and a $42.00 target price on the stock. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and a consensus target price of $39.50.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.